MedPath

Omrix Biopharmaceuticals

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery

Phase 3
Suspended
Conditions
Ovarian Cysts
Endometriosis
Adhesions
Interventions
Biological: ADHEXIL
First Posted Date
2009-03-19
Last Posted Date
2009-12-23
Lead Sponsor
OMRIX Biopharmaceuticals
Target Recruit Count
80
Registration Number
NCT00865488

Safety and Hemostatic Efficacy of Fibrin Fleece in Partial Nephrectomy

Phase 2
Completed
Conditions
Hemostatic Techniques
Nephrectomy
Interventions
Biological: Fleece
First Posted Date
2008-01-18
Last Posted Date
2009-11-06
Lead Sponsor
OMRIX Biopharmaceuticals
Target Recruit Count
30
Registration Number
NCT00598130
Locations
🇮🇱

Meir MC, Kfar Saba, Israel

🇮🇱

Sheaba MC, Tel-Aviv, Israel

🇮🇱

Rabin MC, Tel Aviv, Israel

and more 1 locations

Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil

Phase 1
Conditions
Bilateral Ovarian Disease
Interventions
Biological: Anti adhesion agent
First Posted Date
2007-10-16
Last Posted Date
2008-08-20
Lead Sponsor
OMRIX Biopharmaceuticals
Target Recruit Count
25
Registration Number
NCT00544310
© Copyright 2025. All Rights Reserved by MedPath